✦ LIBER ✦

637 Survival benefit of radical prostatectomy in patients with clinically advanced prostate cancer: Estimations of the number needed to treat based on competing-risks analysis

✍ Scribed by Gandaglia, G.; Sun, M.; Trudeau, V.; Roghmann, F.; Meskawi, M.; Becker, A.; Perrotte, P.; Tian, Z.; Schiffmann, J.; Azizi, M.; Karakiewicz, P.I.; Abdollah, F.

Book ID: 123431937
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 201 KB
Volume: 13
Category: Article
ISSN: 1569-9056
DOI: 10.1016/S1569-9056(14)60627-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PD12-11 SURVIVAL BENEFIT OF RADICAL PROS

PD12-11 SURVIVAL BENEFIT OF RADICAL PROSTATECTOMY IN PATIENTS WITH CLINICALLY ADVANCED PROSTATE CANCER: ESTIMATIONS OF THE NUMBER NEEDED TO TREAT BASED ON COMPETING-RISKS ANALYSIS

✍ Gandaglia, Giorgio; Sun, Maxine; Hu, Jim; Schiffmann, Jonas; Becker, Andreas; Po 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 42 KB

Survival benefit of definitive therapy i

Survival benefit of definitive therapy in patients with clinically advanced prostate cancer: estimations of the number needed to treat based on competing-risks analysis

✍ Gandaglia, Giorgio; Sun, Maxine; Trinh, Quoc-Dien; Becker, Andreas; Schiffmann, 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 838 KB

635 The impact of time to biochemical re

635 The impact of time to biochemical recurrence on cancer-specific mortality in patients with high-risk prostate cancer treated with radical prostatectomy: A competing-risks regression analysis

✍ Gandaglia, G.; Spahn, M.; Joniau, S.; Gontero, P.; Bianchi, M.; Kneitz, B.; Chun 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 202 KB

OP3-06 IMPACT OF TIME TO BIOCHEMICAL REC

OP3-06 IMPACT OF TIME TO BIOCHEMICAL RECURRENCE ON CANCER-SPECIFIC MORTALITY IN PATIENTS WITH HIGH-RISK PROSTATE CANCER TREATED WITH RADICAL PROSTATECTOMY: A COMPETING-RISKS REGRESSION ANALYSIS

✍ Gandaglia, Giorgio; Abdollah, Firas; Bianchi, Marco; Sun, Maxine; Karakiewicz, P 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 43 KB

176 NUMBER NEEDED TO TREAT AND RISK BENE

176 NUMBER NEEDED TO TREAT AND RISK BENEFIT ANALYSIS OF DENOSUMAB VERSUS ZOLEDRONIC ACID IN THE TREATMENT OF CASTRATE-RESISTANT PROSTATE CANCER PATIENTS WITH BONE METASTASES

✍ Xie, Jipan; Diener, Melissa; Wu, Eric; Sorg, Rachael; Yu, Andrew; Namjoshi, Madh 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 47 KB

Reply to Michael Froehner's Letter to th

Reply to Michael Froehner's Letter to the Editor re: Firas Abdollah, Maxine Sun, Jan Schmitges, et al. Cancer-Specific and Other-Cause Mortality After Radical Prostatectomy Versus Observation in Patients with Prostate Cancer: Competing-Risks Analysis of a Large North American Population-Based Cohort. Eur Urol 2011;60:920–30

✍ Firas Abdollah; Maxine Sun; Francesco Montorsi; Pierre I. Karakiewicz 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 67 KB